Navigation Links
ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study
Date:4/15/2008

ontinued development and commercialization of ANX-530; the potential for regulatory authorities to require additional preclinical work or other clinical requirements to support regulatory filings; patent and non-patent exclusivity covering Navelbine; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at http://www.sec.gov.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date on which it was made.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting
2. Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology
3. Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
4. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
5. Recent Study Confirms Alimentary Healths Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome
6. Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder
7. ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients
8. Magnifi Group Demonstrates Industrys First Interactive Educational Program (IEP) for Spine Fellows
9. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
10. Job-related stress: NIST demonstrates fatigue effects in silicon
11. USGI Medical Demonstrates First System for Gastrotomy Closure in NOTES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 The ... Spain , available today on PharmaBoardroom.com ... the Eurozone crisis that rocked the Spanish economy in 2009, ... Spanish pharma community has remained pragmatic in times of trouble. ... is still the fifth biggest European market, and the general ...
(Date:9/18/2014)... -- About POCT POCT, also ... laboratory. It helps in making fast clinical decisions, ... POCT is gaining popularity due to the increasing ... diabetes, heart disease, and obesity. It is generally ... minimize errors during the diagnosis of patients. POCT ...
(Date:9/18/2014)...  Health Enhancement Products, Inc. (OTCQB: HEPI), a ... and metabolic processes, is pleased to announce the addition of ... Nola E. Masterson , a California ... September 17, 2014. "We,re very pleased and ... states Andrew Dahl , President and CEO. "She joins ...
(Date:9/18/2014)... 18, 2014 On Tuesday, Secretary of ... Jim Risch for National Lab Day on the Hill. ... the national laboratory system. Durbin and Risch also formally ... increase awareness of the reach of the national labs ... to address some of our nation's most pressing challenges. ...
Breaking Biology Technology:PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3POCT Market in China 2014-2018 2Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 3
... /PRNewswire-FirstCall/ - Atrium Innovations Inc.,(TSX: ATB), a recognized ... endorsed products for the health and,nutrition industries, today ... Pierre Fitzgibbon, will present a company overview,at the ... on,Tuesday, August 12, 2008 at 11 am (eastern ...
... HALIFAX, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. ... patent approval,from the Japanese Patent Office for its ... response and methods for their,preparation, claims broad exclusivity ... disease can be produced using a vaccine comprising ...
... The definitive biotechnology industry primer, now in ... Logos Press announces the third,edition of ... leading textbook for biotechnology business courses. This ... material, including new chapters, new,and updated figures ...
Cached Biology Technology:ImmunoVaccine Technologies Broadens Its Patent Protection to Japan 2New Book on the Business of Biotechnology 2
(Date:9/18/2014)... No matter how many times it,s demonstrated, ... communicating creatures. , But by using a ... radically alter their behavior to suit their population. ... them are present, and act accordingly. , Once ... it may change from innocuous to pathogenic, or ...
(Date:9/18/2014)... Our genetic information is stored in DNA, tiny strands ... of our bodies. To express this genetic data, our ... the instructions into proteins that perform tasks in our ... new type of RNA molecule. Unlike all other known ... RNA. Although circRNA molecules are abundant, little has been ...
(Date:9/18/2014)... Americans across racial and ethnic groups describe losing ... their day-to-day life, more so than other conditions ... (57% of African-Americans, 49% of non-Hispanic whites, 43% ... which disease or ailment is the worst that ... African-Americans followed by AIDS/HIV. Hispanics and Asians ...
Breaking Biology News(10 mins):Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3
... Oct. 18 Reportlinker.com announces that a new ... Global Biometrics Industry ... report analyzes the worldwide markets for Biometrics in ... (Automated Fingerprint Identification System), Non-AFIS/Finger Scan, Hand Geometry, ...
... the MPI of Biochemistry and GSK pursues the objective ... development work is based on the research findings of ... and fellow scientist Mathias Bcker successfully described the role ... in connection with the development of type II diabetes, ...
... change on the microbial communities of two important ecosystemsthe ... a University of Oklahoma research group has been awarded ... to Jizhong Zhou, OU professor of botany and microbiology ... results of these studies could potentially contribute to the ...
Cached Biology News:Reportlinker Adds Global Biometrics Industry 2Reportlinker Adds Global Biometrics Industry 3Reportlinker Adds Global Biometrics Industry 4Reportlinker Adds Global Biometrics Industry 5Reportlinker Adds Global Biometrics Industry 6Reportlinker Adds Global Biometrics Industry 7Reportlinker Adds Global Biometrics Industry 8Reportlinker Adds Global Biometrics Industry 9Reportlinker Adds Global Biometrics Industry 10Reportlinker Adds Global Biometrics Industry 11Reportlinker Adds Global Biometrics Industry 12Reportlinker Adds Global Biometrics Industry 13Reportlinker Adds Global Biometrics Industry 14Reportlinker Adds Global Biometrics Industry 15Reportlinker Adds Global Biometrics Industry 16Reportlinker Adds Global Biometrics Industry 17Reportlinker Adds Global Biometrics Industry 18Reportlinker Adds Global Biometrics Industry 19Reportlinker Adds Global Biometrics Industry 20Reportlinker Adds Global Biometrics Industry 21Reportlinker Adds Global Biometrics Industry 22Reportlinker Adds Global Biometrics Industry 23Cooperation in diabetes research 2
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
RABBIT ANTI GLYCINE...
Request Info...
... (CMV) pp65 Antigenemia Immunofluorescence Assay (IFA) is ... matrix protein pp65 of CMV in isolated ... Erythrocyte Lysis Buffer - ... mL of buffered ammonium chloride. (NH4CL) ...
Biology Products: